Lytvynchuk Lyubomyr, Sergienko Andrii, Lavrenchuk Galina, & Petrovski Goran. (2015). Antiproliferative, Apoptotic, and Autophagic Activity of Ranibizumab, Bevacizumab, Pegaptanib, and Aflibercept on Fibroblasts: Implication for Choroidal Neovascularization.
Chicago Style (17th ed.) CitationLytvynchuk Lyubomyr, Sergienko Andrii, Lavrenchuk Galina, and Petrovski Goran. Antiproliferative, Apoptotic, and Autophagic Activity of Ranibizumab, Bevacizumab, Pegaptanib, and Aflibercept on Fibroblasts: Implication for Choroidal Neovascularization. Hindawi Publishing Corporation, 2015.
MLA idézésLytvynchuk Lyubomyr, et al. Antiproliferative, Apoptotic, and Autophagic Activity of Ranibizumab, Bevacizumab, Pegaptanib, and Aflibercept on Fibroblasts: Implication for Choroidal Neovascularization. 2015.